UCB has a fundamental commitment to enabling people living with severe diseases, their caregivers & families to live their best lives. We continuously innovate to bring differentiated solutions with unique outcomes, which help specific patients achieve their life goals. To deliver on that commitment now and into the future, sustainability is a strategic imperative for us.
UCB
Company · Belgium · EU Transparency Register 294359117093-66
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1048 companies & groups on this site, they rank #638 by legislative files engaged — a count of participation, not a measure of influence.
Declares membership of
- EFPIA = European Federation of Pharmaceutical Industries and Associations
- (http://efpia.eu/)
Self-declared to the EU Transparency Register (snapshot 2 Sept 2026).
- Register category
- Companies & groups
- Head office
- Brussels, Belgium
Self-declared to the EU Transparency Register (snapshot 2 Sept 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track UCB in PolicySpeak: request access →
Work at UCB? so we know who speaks for it.
Their record over time
UCB filed 2 positions between 6 Jan 2021 and 26 Apr 2021, across 2 of the 583 legislative files tracked here.
What they argued
UCB is dedicated to finding unique solutions for diseases with high degree of patient need. Regardless of the population size, it’s patients’ needs that direct our efforts. Our ambition for patients relies on our ability to innovate & bring differentiated solutions with unique outcomes that help specific patients achieve their goals.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put UCB next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
Showing 5 of 52.
Is this your organization?
Everything on this page comes from UCB’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.